GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jingfeng Pharmaceutical Co Ltd (SZSE:000908) » Definitions » EBITDA Margin %

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) EBITDA Margin % : 12.63% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Hunan Jingfeng Pharmaceutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hunan Jingfeng Pharmaceutical Co's EBITDA for the three months ended in Mar. 2024 was ¥12.7 Mil. Hunan Jingfeng Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥100.6 Mil. Therefore, Hunan Jingfeng Pharmaceutical Co's EBITDA margin for the quarter that ended in Mar. 2024 was 12.63%.


Hunan Jingfeng Pharmaceutical Co EBITDA Margin % Historical Data

The historical data trend for Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jingfeng Pharmaceutical Co EBITDA Margin % Chart

Hunan Jingfeng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -55.58 -97.55 6.02 2.62 -13.59

Hunan Jingfeng Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.54 4.25 -4.29 -150.70 12.63

Competitive Comparison of Hunan Jingfeng Pharmaceutical Co's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Hunan Jingfeng Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % falls into.



Hunan Jingfeng Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-89.273/656.894
=-13.59 %

Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=12.706/100.576
=12.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Jingfeng Pharmaceutical Co  (SZSE:000908) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hunan Jingfeng Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Hunan Jingfeng Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Business Description

Traded in Other Exchanges
N/A
Address
500 Zhangyang Road, Pudong New District, 30th Floor, China Resources Times Square, Shanghai, CHN
Hunan Jingfeng Pharmaceutical Co Ltd is engaged in the manufacturing of pharmaceutical products in China. The company offers Chemical medicine, Biological medicine, and Traditional Chinese medicine. Some of its products include Lemai Wan, Analgesic, Fuping Capsules, and Tongdi Capsules among others.
Executives
Zhou Shen Dong Supervisors
Ye Xiang Wu Directors, executives
Ma Xian Peng Executives
Cong Shu Fen Executives
Zhang Jun Guo Executives
Jian Wei Guang Directors, executives
Bi Yuan Secretary, Director
Ou Yang Yan Li Secretary, Director
Luo Li Director
Luo Bin Director
Li Tong Directors, executives
Wei Ze Chun Director
Tang Zhi Executives
Ou Yang Chun Bao Executives
Mao Hui Executives

Hunan Jingfeng Pharmaceutical Co (SZSE:000908) Headlines

No Headlines